Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Skylight Health Group Inc (SLHGh)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
0.0200 0.0000    0.00%
- Closed. Currency in CAD ( Disclaimer )
Type:  Equity
Market:  Canada
  • Volume: 0
  • Bid/Ask: 0.0150 / 0.0250
  • Day's Range: 0.0200 - 0.0250
Skylight Health Group 0.0200 0.0000 0.00%

SLHGh Recent Sentiments

 
This page contains information on users’ sentiments for the Skylight Health Group Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Dec 30, 2022 Ryan James   0.3400 Jan 20, 2023 @ 0.2800 -17.65%
May 26, 2022 Rahim Amrally   0.8200 Jun 17, 2022 @ 0.8000 -2.44%
Sep 20, 2021 Frederic Demers   3.9100 Oct 15, 2021 @ 3.6000 -7.93%
Jul 02, 2021 Frederic Demers   5.0800 Jul 23, 2021 @ 4.3800 -13.78%
May 31, 2021 Frederic Demers   6.8500 Jun 25, 2021 @ 4.9600 -27.59%
May 04, 2021 Rodrigo Barros   1.4300 May 28, 2021 @ 7.0600 +393.71%
Apr 30, 2021 Leung Benjamin   1.5900 May 21, 2021 @ 1.4300 -10.06%
Apr 27, 2021 Rodrigo Barros   1.4600 Apr 29, 2021 @ 1.4500 -0.68%
Apr 06, 2021 Frederic Demers   1.3100 Apr 30, 2021 @ 1.6100 +22.90%
Apr 05, 2021 Jamal William   1.3300 Apr 30, 2021 @ 1.6100 +21.05%
Mar 03, 2021 Salim Jivani   1.5100 Mar 26, 2021 @ 1.1700 +22.52%
Feb 19, 2021 Kevin Ka   1.7800 Mar 12, 2021 @ 1.2900 -27.53%
Feb 18, 2021 John Villegas   1.8900 Mar 12, 2021 @ 1.2900 -31.75%
Feb 11, 2021 Raynald Lachance   1.5700 Mar 05, 2021 @ 1.3600 -13.38%
Feb 03, 2021 hari patel   1.2200 Feb 26, 2021 @ 1.5000 +22.95%
Jan 12, 2021 Peter McHatten   1.3500 Jan 12, 2021 @ 0.0000 0.00%
Jan 07, 2021 qiao geng   1.4800 Jan 29, 2021 @ 1.1800 -20.27%
Dec 17, 2020 Salim Jivani   1.1300 Jan 06, 2021 @ 1.4000 -23.89%
Dec 10, 2020 Pierre Paul Cote   1.1200 Jan 01, 2021 @ 1.1700 +4.46%
Nov 18, 2020 Jack Gremmen   0.4150 Dec 11, 2020 @ 1.1100 -167.47%
Oct 26, 2020 Hung Nguyen   0.5500 Nov 20, 2020 @ 0.4700 -14.55%
May 14, 2019 Hung Nguyen   0.2600 Jun 07, 2019 @ 0.1800 -30.77%
Apr 04, 2019 Hamid Maqsudi   0.3150 Apr 26, 2019 @ 0.3000 -4.76%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

SLHGh Comments

Write your thoughts about Skylight Health Group Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mike Powell
Mike Powell Nov 28, 2022 3:19PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I’m impressed with Skylight Health Group’s recent Q3 ‘22 results - particularly the fact that this tiny $25.4M market cap company has generated $20.8M revenues by Q3. Their future outlook is equally positive now that they’ve reached sufficient scale to organically grow their lines of businesses including Medicare and Medicare Advantage.
Reply
0 0
Report
Mike Powell
Mike Powell Nov 24, 2022 4:07PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Skylight Health Group recently reported positive results from their Q3 ‘22 results including revenue growth of +152% YoY reaching $20.8M. Even stronger results from their cost-saving initiatives reducing annual cost base by $10M+. Their forthcoming strategy is to develop growth organically now they’ve reached sufficient scale and this is through growth in their business lines including Medicare and Medicare Advantage.
Reply
0 0
Report
Jeremy Lin
Jeremy Lin Nov 08, 2022 5:27PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Healthcare in the US has always been an important market highly resistant to fluctuations in the economy. $5M isn't a small amount of money, so with a multi-billion dollar company backing them, Skylight has significant potential to scale the business as they continue to develop their clinical network.
Reply
0 0
Report
Jeremy Lin
Jeremy Lin Oct 28, 2022 3:12PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The recent capital raise's benefits greatly outweigh the dilution that it'll create. In a market like this, the companies that are improving their margins and have significant backing will be the ones that'll benefit. Echelon Capital even stated that the company could more than triple from here due to growth potential and the current undervalued status against industry peers: https://www.cantechletter.com/2022/10/skylight-health-is-more-than-a-triple-from-here-says-echelon/
Reply
0 0
Report
Jeremy Lin
Jeremy Lin Oct 25, 2022 2:43PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The $5M will go a long way for company development. The institutional backing only shows that there's potential for significant growth here as Skylight continues to aggressively expand operations across the US and improve EBIDTA margins each quarter.
Reply
0 0
Report
Jeremy Lin
Jeremy Lin Oct 18, 2022 2:53PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
One of the main problems with medical clinics today is a lack of optimization both for costs and administration. Skylight's network is creating a more effective environment where patients can get the treatment they need, and the clinic can maximize profitability. Considering the growth projections and current valuation, there's a lot of untapped potential.
Reply
0 0
Report
Jeremy Lin
Jeremy Lin Oct 13, 2022 1:26PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Now trading on the OTCQX and have received DTC Eligibility under SLHGF. This means that the company will now have more transparency and will be more visible to US investors who are interested in the company and its rapidly expanding footprint across the US.
Reply
0 0
Report
Matty Silverstoone
Matty Silverstoone Aug 17, 2021 12:02PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Very impressed with the financial results for Q2! Rev increased 184%, 13% organic growth from existing primary care clinics, and $11.8M cash balance. Love to see them achieve their largest rev quarter and ending it with the addition of new clinics, providers and patient panels.
Reply
0 0
Report
Matty Silverstoone
Matty Silverstoone Aug 09, 2021 3:08PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Lake Street recently initiated coverage for $SLHG with a buy rating and a pt of $8. As they continue to acquire clinics and focus on their value-based care model resulting in improved patient care, this one has lots of potential imo.
Reply
0 0
Report
Henry Wong
Henry Wong Jul 26, 2021 3:16PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Skylight Health Group is an extremely unique Healthcare service tech provider operating 30 clinics, across 14 states, and serving over 120,000 patients - and one of the fastest growing multi-disciplinary health systems in the US. With their VBC model for payment disrupting the industry FFS standard, they are market leaders that emphasize quality over volume leading to better patient outcomes, reduced cost for delivery, and driving better financial performance. Their recent ACO partnership acquisitions provide clear and significant strides toward this foundational goal as they will not be participating in the Medicare Shared Savings programs effective Jan 1, 2022. $SLHG is definitely one to watch!
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email